BR112014017834A8 - Sistema de distribuição de fármacos - Google Patents
Sistema de distribuição de fármacosInfo
- Publication number
- BR112014017834A8 BR112014017834A8 BR112014017834A BR112014017834A BR112014017834A8 BR 112014017834 A8 BR112014017834 A8 BR 112014017834A8 BR 112014017834 A BR112014017834 A BR 112014017834A BR 112014017834 A BR112014017834 A BR 112014017834A BR 112014017834 A8 BR112014017834 A8 BR 112014017834A8
- Authority
- BR
- Brazil
- Prior art keywords
- core
- delivery system
- membrane
- distribution system
- active substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
Abstract
SISTEMA DE DISTRIBUIÇÃO DE DROGAS. A presente invenção refere-se a um novo sistema de distribuição de droga para a liberação controlada de substância(s) terapeuticamente ativa(s) em uma taxa de liberação predeterminada, essencialmente constante através de um período de tempo prolongado. O sistema de distribuição compreende pelo menos um núcleo compreendendo a(s) dita(s)substância(s) terapeuticamente ativa(s), pelo menos uma membrana encerrando o núcleo e uma camada inter mediária de um material substancialmente inerte, em que a camada intermediária é aplicada entre o núcleo e a membrana ou entre duas camadas de membrana.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20125069 | 2012-01-23 | ||
| FI20125069 | 2012-01-23 | ||
| PCT/FI2013/050068 WO2013110856A1 (en) | 2012-01-23 | 2013-01-22 | A drug delivery system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112014017834A2 BR112014017834A2 (pt) | 2017-06-20 |
| BR112014017834A8 true BR112014017834A8 (pt) | 2017-07-11 |
| BR112014017834B1 BR112014017834B1 (pt) | 2021-05-18 |
Family
ID=47666152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014017834-8A BR112014017834B1 (pt) | 2012-01-23 | 2013-01-22 | sistema de distribuição de fármacos |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US10500381B2 (pt) |
| EP (1) | EP2806893B1 (pt) |
| JP (1) | JP6236401B2 (pt) |
| KR (1) | KR102004014B1 (pt) |
| CN (1) | CN104144702B (pt) |
| AR (1) | AR089765A1 (pt) |
| AU (1) | AU2013213514B2 (pt) |
| BR (1) | BR112014017834B1 (pt) |
| CA (1) | CA2861947A1 (pt) |
| CL (1) | CL2014001935A1 (pt) |
| CO (1) | CO7020911A2 (pt) |
| CR (1) | CR20140358A (pt) |
| CU (1) | CU24431B1 (pt) |
| CY (1) | CY1120773T1 (pt) |
| DK (1) | DK2806893T3 (pt) |
| DO (1) | DOP2014000171A (pt) |
| EA (1) | EA032208B1 (pt) |
| EC (1) | ECSP14010605A (pt) |
| ES (1) | ES2691635T3 (pt) |
| HK (1) | HK1203802A1 (pt) |
| HR (1) | HRP20181707T1 (pt) |
| IL (1) | IL233599B (pt) |
| LT (1) | LT2806893T (pt) |
| MX (1) | MX355961B (pt) |
| MY (1) | MY172812A (pt) |
| NZ (1) | NZ627461A (pt) |
| PE (1) | PE20141818A1 (pt) |
| PH (1) | PH12014501654B1 (pt) |
| PL (1) | PL2806893T3 (pt) |
| PT (1) | PT2806893T (pt) |
| RS (1) | RS57911B1 (pt) |
| SG (1) | SG11201404032SA (pt) |
| SI (1) | SI2806893T1 (pt) |
| TR (1) | TR201815247T4 (pt) |
| TW (1) | TWI626951B (pt) |
| UA (1) | UA116197C2 (pt) |
| UY (1) | UY34583A (pt) |
| WO (1) | WO2013110856A1 (pt) |
| ZA (1) | ZA201406206B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102237799B1 (ko) | 2012-11-14 | 2021-04-08 | 더블유.알. 그레이스 앤드 캄파니-콘. | 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물 |
| ES2699003T3 (es) * | 2014-06-28 | 2019-02-06 | Laboratorios Andromaco S A | Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, usado para la prevención de partos prematuros |
| KR20180093255A (ko) * | 2015-12-21 | 2018-08-21 | 바이엘 오와이 | 질용 고리의 제조 방법 |
| WO2018202574A1 (en) | 2017-05-04 | 2018-11-08 | Bayer Oy | Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception |
| WO2019063382A1 (en) | 2017-09-27 | 2019-04-04 | Bayer Oy | METHOD FOR MODIFYING THE RELEASE OF A THERAPEUTICALLY ACTIVE AGENT FROM AN ELASTOMERIC MATRIX |
| CN109954198B (zh) * | 2017-12-25 | 2021-10-12 | 先健科技(深圳)有限公司 | 药物球囊及其制备方法 |
| JP2022520667A (ja) * | 2019-02-19 | 2022-03-31 | パーティクル サイエンシーズ， インコーポレイテッド | 隔室化された薬物送達デバイス |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19975054I2 (de) * | 1987-08-08 | 2000-04-13 | Akzo Nobel Nv | Kontrazeptives Implantat |
| US5660848A (en) * | 1994-11-02 | 1997-08-26 | The Population Council, Center For Biomedical Research | Subdermally implantable device |
| US5916595A (en) * | 1997-12-12 | 1999-06-29 | Andrx Pharmaceutials, Inc. | HMG co-reductase inhibitor |
| NZ330726A (en) * | 1998-06-18 | 2000-10-27 | Dec Res | Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate |
| AU2001258442A1 (en) | 2000-05-10 | 2001-11-20 | Leiras Oy | Drug delivery device, especially for the delivery of levonorgestrel |
| WO2002032433A1 (en) * | 2000-10-20 | 2002-04-25 | Leiras Oy | Drug delivery system |
| US20040247674A1 (en) | 2001-08-31 | 2004-12-09 | Timo Haapakumpu | Drug delivery system |
| DE10209979A1 (de) | 2002-03-07 | 2003-09-25 | Ratiopharm Gmbh | Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung |
| US20050013863A1 (en) * | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
| PL1740154T3 (pl) | 2004-03-12 | 2009-11-30 | Biodel Inc | Kompozycje insuliny o ulepszonym wchłanianiu |
| DK1629844T4 (da) | 2004-07-13 | 2012-05-29 | Bayer Schering Pharma Oy | Retarderet indgivelsessystem med kontrolleret initialudbrud |
| US20060024362A1 (en) * | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
| US20090208575A1 (en) * | 2005-01-03 | 2009-08-20 | Lupin Limited | Pharmaceutical Composition Of Acid Labile Substances |
| US9198871B2 (en) * | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US20060165776A1 (en) * | 2005-08-31 | 2006-07-27 | Ramesh Sesha | Antidepressant oral pharmaceutical compositions |
| US8137327B2 (en) | 2006-06-16 | 2012-03-20 | Family Health International | Vaginal drug delivery system and method |
| JP2010509964A (ja) * | 2006-11-20 | 2010-04-02 | ナームローゼ・フエンノートチヤツプ・オルガノン | らせん形薬物送達システム |
| US8741329B2 (en) * | 2007-09-21 | 2014-06-03 | Merck Sharp & Dohme B.V. | Drug delivery system |
| TW200927141A (en) | 2007-11-22 | 2009-07-01 | Bayer Schering Pharma Oy | Vaginal delivery system |
| EP2140860A1 (en) | 2008-07-03 | 2010-01-06 | Bayer Schering Pharma Oy | An improved method of contraception |
| FI121000B (fi) | 2008-11-19 | 2010-06-15 | Bayer Schering Pharma Oy | Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi |
| CN103347496A (zh) * | 2010-12-27 | 2013-10-09 | 道康宁公司 | 药物递送分散体以及由其形成的膜 |
-
2013
- 2013-01-21 AR ARP130100173A patent/AR089765A1/es unknown
- 2013-01-22 CU CU2014000094A patent/CU24431B1/es unknown
- 2013-01-22 PL PL13702817T patent/PL2806893T3/pl unknown
- 2013-01-22 UY UY0001034583A patent/UY34583A/es not_active Application Discontinuation
- 2013-01-22 KR KR1020147023356A patent/KR102004014B1/ko active IP Right Grant
- 2013-01-22 CA CA2861947A patent/CA2861947A1/en not_active Abandoned
- 2013-01-22 RS RS20181218A patent/RS57911B1/sr unknown
- 2013-01-22 DK DK13702817.1T patent/DK2806893T3/en active
- 2013-01-22 AU AU2013213514A patent/AU2013213514B2/en not_active Ceased
- 2013-01-22 TW TW102102306A patent/TWI626951B/zh not_active IP Right Cessation
- 2013-01-22 LT LTEP13702817.1T patent/LT2806893T/lt unknown
- 2013-01-22 MY MYPI2014701990A patent/MY172812A/en unknown
- 2013-01-22 ES ES13702817.1T patent/ES2691635T3/es active Active
- 2013-01-22 MX MX2014008906A patent/MX355961B/es active IP Right Grant
- 2013-01-22 WO PCT/FI2013/050068 patent/WO2013110856A1/en active Application Filing
- 2013-01-22 CL CL2014001935A patent/CL2014001935A1/es unknown
- 2013-01-22 UA UAA201409275A patent/UA116197C2/uk unknown
- 2013-01-22 SG SG11201404032SA patent/SG11201404032SA/en unknown
- 2013-01-22 NZ NZ627461A patent/NZ627461A/en not_active IP Right Cessation
- 2013-01-22 PT PT13702817T patent/PT2806893T/pt unknown
- 2013-01-22 JP JP2014552669A patent/JP6236401B2/ja active Active
- 2013-01-22 TR TR2018/15247T patent/TR201815247T4/tr unknown
- 2013-01-22 CN CN201380006458.1A patent/CN104144702B/zh active Active
- 2013-01-22 EA EA201400834A patent/EA032208B1/ru not_active IP Right Cessation
- 2013-01-22 PE PE2014001141A patent/PE20141818A1/es active IP Right Grant
- 2013-01-22 BR BR112014017834-8A patent/BR112014017834B1/pt not_active IP Right Cessation
- 2013-01-22 SI SI201331216T patent/SI2806893T1/sl unknown
- 2013-01-22 EP EP13702817.1A patent/EP2806893B1/en active Active
- 2013-01-22 US US14/371,848 patent/US10500381B2/en not_active Expired - Fee Related
-
2014
- 2014-07-10 IL IL233599A patent/IL233599B/en active IP Right Grant
- 2014-07-18 PH PH12014501654A patent/PH12014501654B1/en unknown
- 2014-07-23 DO DO2014000171A patent/DOP2014000171A/es unknown
- 2014-07-23 CO CO14160132A patent/CO7020911A2/es unknown
- 2014-07-23 CR CR20140358A patent/CR20140358A/es unknown
- 2014-07-23 EC ECIEPI201410605A patent/ECSP14010605A/es unknown
- 2014-08-22 ZA ZA2014/06206A patent/ZA201406206B/en unknown
-
2015
- 2015-05-05 HK HK15104265.3A patent/HK1203802A1/xx not_active IP Right Cessation
-
2018
- 2018-10-17 HR HRP20181707TT patent/HRP20181707T1/hr unknown
- 2018-10-18 CY CY181101075T patent/CY1120773T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014017834A8 (pt) | Sistema de distribuição de fármacos | |
| CR20150664A (es) | Moduladores de los receptores de estrógeno y sus usos | |
| UY34832A (es) | TIAZOLES SUSTITUIDOS POR CARBOXAMIDA O SULFONAMIDA Y DERIVADOS RELACIONADOS COMO MODULADORES PARA EL RECEPTOR NUCLEAR HUÉRFANO RORy (lambda) | |
| CL2014001855A1 (es) | Compuestos derivados de imidazopirrolidinona o sus sales, formas cristalinas; composicion farmaceutica que los comprende; y su uso para el tratamiento de un trastorno o enfermedad mediada por la actividad de mdm2 y/o mdm4 tales como enfermedades proliferativas, especialmente cancer. | |
| BR112013030599A2 (pt) | núcleo absorvente para artigos absorventes descartáveis | |
| CL2015000295A1 (es) | Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades. | |
| CR20150326A (es) | Inhibidores de autotaxina | |
| BR112018010671A8 (pt) | dispositivos e métodos de distribuição de fármaco com mudança de forma | |
| ECSP16078782A (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
| CL2015001279A1 (es) | Compuestos derivados de piridina, inhibidores del transportador de uratos urat 1; composicion farmaceutica que los comprende; uso para el tratamiento o prevencion de enfermedades tales como gota, hiperuricemia, hipertensión, enfermedades renales, entre otras. | |
| CL2015002608A1 (es) | Compuesto de amino-pirazol y usos medicinales relacionados. | |
| MX350875B (es) | Formas de dosificacion farmaceutica de liberacion controlada. | |
| CL2015000976A1 (es) | Compuestos de 2-fenil-5-heterociclil-tetrahidro-2h-piran-3-amina para uso en el tratamiento de diabetes y sus trastornos asociados. | |
| EA201400628A1 (ru) | Трансдермальная терапевтическая система для введения фентанила или его аналога | |
| BR112013014616A2 (pt) | sistema terapêutico transdérmico para a administração de uma substância ativa | |
| CL2014000490A1 (es) | Compuestos derivados de pirazol y sus sales, con actividad inhibidora de sglt1; composicion farmaceutica que los comprende; y su uso para tratar o prevenir diabetes. | |
| EA201591196A1 (ru) | Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств | |
| NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
| BR112015001521A2 (pt) | previsão de resposta ao tratamento para inibidor jak/stat | |
| CO6920289A2 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib. | |
| WO2014188329A3 (en) | Transdermal extended dosing of pramipexole for neurological disorders | |
| EP3880175A4 (en) | TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM | |
| GT201300032A (es) | Composicion farmaceutica de liberacion prolongada de trimetazidina | |
| CL2014001643A1 (es) | Compuestos derivados de quinolina, como inhibidores de la enzima pde10a; composicion farmaceutica que los comprende; y su uso para el tratamiento de un trastorno psiquiatrico o neurodegenerativo. | |
| UY34755A (es) | Agentes para el control de la glycaspis brimblecombei |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/01/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2706 DE 16-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |